Moreover, plasma calprotectin has been proposed as a diagnostic marker of AIS [13], and inhibition of S100A9 has been reported to suppress thrombus formation in experimental models of stroke [14, 15]. This evidence concerns the gene S100A9 and androgen insensitivity syndrome.